Systimmune Inc.
Clinical trials sponsored by Systimmune Inc., explained in plain language.
-
New hope for leukemia patients: experimental drug BL-M11D1 enters human trials
Disease control Recruiting nowThis early-stage study tests a new drug called BL-M11D1 in 120 adults whose acute myeloid leukemia has returned or not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it helps control the disease. Participants must …
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 29, 2026 01:50 UTC
-
New hope for advanced cancers: experimental drug targets HER2
Disease control Recruiting nowThis early-phase study tests a new drug called BL-M07D1 in people with advanced solid tumors that have a protein called HER2. The goal is to see if the drug is safe and can shrink tumors. About 280 adults with cancers like breast, lung, or stomach cancer who have tried at least t…
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC